Correction: Phase I/Ib Clinical Trial of Sabatolimab, an Anti–TIM-3 Antibody, Alone and in Combination with Spartalizumab, an Anti–PD-1 Antibody, in Advanced Solid Tumors

作者：Giuseppe Curigliano, Hans Curigliano, Nicolas Mach, Toshihiko Doi, David Wai-Meng Tai, Patrick M. Forde, John Sarantopoulos, Philippe Lucien Bedard, Chia‐Chi Lin, Frank Stephen Hodi, Sofie Wilgenhof, Armando Santoro, Catherine A. Sabatos-Peyton, Tyler A. Longmire, Alexandros Xyrafas, Haiying Sun, Sabine Gutzwiller, Luigi Manenti, Aung Naing · 发表于：Clinical Cancer Research · 年份：2024 · DOI：10.1158/1078-0432.ccr-24-2131 · 被引用次数：7 · 研究领域：CAR-T cell therapy research、Monoclonal and Polyclonal Antibodies Research、Galectins and Cancer Biology